Share Name Share Symbol Market Type Share ISIN Share Description
Deltex Medical Group Plc LSE:DEMG London Ordinary Share GB0059337583 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 1.125 2,612 08:00:00
Bid Price Offer Price High Price Low Price Open Price
1.05 1.20 1.125 1.125 1.125
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 4.96 -1.34 -0.30 6
Last Trade Time Trade Type Trade Size Trade Price Currency
13:41:57 O 976 1.069 GBX

Deltex Medical (DEMG) Latest News

More Deltex Medical News
Deltex Medical Takeover Rumours

Deltex Medical (DEMG) Discussions and Chat

Deltex Medical Forums and Chat

Date Time Title Posts
29/11/201909:49Deltex Medical - a British success story!10,562
16/10/201914:48Deltex Medical - winner or doomed to fail? 271
19/6/201811:15Deltex Medical interview with new CEO1
06/6/201820:52Interview with Deltex Medical Group 1
14/7/201410:16Deltex Medical-Optimal Growth Stock10,005

Add a New Thread

Deltex Medical (DEMG) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Deltex Medical trades in real-time

Deltex Medical (DEMG) Top Chat Posts

Deltex Medical Daily Update: Deltex Medical Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker DEMG. The last closing price for Deltex Medical was 1.13p.
Deltex Medical Group Plc has a 4 week average price of 1.08p and a 12 week average price of 1.05p.
The 1 year high share price is 2p while the 1 year low share price is currently 0.85p.
There are currently 520,272,871 shares in issue and the average daily traded volume is 126,931 shares. The market capitalisation of Deltex Medical Group Plc is £5,853,069.80.
arf dysg: It's not a share, it's a company. Alternatively, if you're asking "how is the share price doing?" then the answer is blindingly obvious. If you can't see the share-price chart, then how will you see these answers, which tell you to look at the share price chart?
gbenson1: The share price action in DEMG never fails to amaze me, only the other day somebody bought 1 million+ shares and the price never budged, today there are in the region of 900k of sales and the Sp drops 16%, something is a foot, hopefully all will be revealed in the following days!!
schloo: Agreed although I don't think acquirers will be that bothered by the balance sheet. Cheetah never generated any cash and Baxter still paid a very high price Cheetah raised $12m of equity in 2017 and $7m more in 2018, none of it from new investors, suggesting it was a struggle. They then raised another $20m in venture debt earlier this year so balance sheet can not be pretty For DEMG, as a listed company whereas Cheetah was private, the key point about being cash flow positive is that there is no longer any incentive for the market to massively undervalue the company in anticipation of buying new shares super cheap in a placing The Cheetah deal shows that someone might well be willing to pay big money for DEMG right now, but it simply won't happen until the share price gets to a half sensible place. No reason, now its cash positive, why that should not happen now either
buywell3: Not a good day today I c MrC I wonder if news has leaked re upcoming results ? A penny for your thoughts and for the share price perhaps
buywell3: 8% is 100k a year in interest These loan notes are going to get issued a lot cheaper than 6p as has already happened with some Could be circa another 100M shares to get issued at 1.25p IMO Partial redemption of convertible loan note Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring ("ODM"), gives notice that it has issued 2,000,000 New Ordinary Shares of 1p each at a price of 1.25p each, equal to the closing share price on 17 May 2018. As stated in the Company's shareholder circular (the "Circular"), published on 24 January 2018, it was agreed that a holding of £25,000 nominal amount of convertible loan notes could be redeemed. The holder of these convertible loan notes requested that the nominal amount be reinvested in the Company at the same price as the fundraising in January. In the light of this, the Directors have allotted 2,000,000 New Ordinary Shares of 1p each using the allotment authorities granted to the Directors at the annual general meeting of the Company on 9 June 2017.
buywell3: A subscription raising £1.125 million by way of new convertible loan notes due 2019 ("Loan Notes") with an interest rate of 8% and a conversion price of 6 pence. The Loan Notes are repayable in full on the third anniversary of their date of issue although they may be prepaid in whole or in part at the Company's discretion at any time. Loan Notes The Company intends to raise £1.125 million by the issue of the Loan Notes. Of these, Imperialise Limited (a company associated with Nigel Keen, non-executive Chairman of the Company), has agreed to subscribe for £500,000 nominal amount of the Loan Notes. The Loan Notes are unsecured and interest is payable at 8% per annum. The Loan Notes are repayable in full on the third anniversary of their date of issue although they may be prepaid in whole or in part at the Company's discretion at any time. The Loan Notes are convertible at any time up until repayment into 18,750,000 ordinary shares at the effective price of 6p, being a premium of 30 per cent. over the share price at close of business on 2 February 2016 and a premium of 50 per cent. over the Issue Price. The Company can also enforce conversion if the ordinary share price is equal to or exceeds 18p for any period of 30 consecutive days. If the Company elects to prepay all or any of the Loan Notes, it will issue to the note holders warrants to subscribe for ordinary shares at 6 pence per share (at the rate of 5,000 warrants for every £300 nominal of Loan Notes repaid (and pro rata for any greater or lesser amount repaid)). Such warrants will be exercisable within the same period as corresponds to the conversion rights previously attaching to the Loan Notes prepaid.
doglover2003: I suspect that the profitability will be insufficient to suggest the possibility of a dividend. Therefore, I don't see why there would be a market re-rating. However, I hope you are right. The profitable base really presents a platform based on which the company can go forward without the necessity of further funding. Good news-flow suggesting future additional orders would then look more encouraging of a re-rating. That seems to be where we are at present and today's drift in the share price suggests impatience in some quarters.
waywardlad: Where is buywell, only appears when share price is on its way down?
mrc2u: The endpoint for this type of business is to be acquired by a larger one who can take the technology and roll it out to mass markets with infinitely greater marketing resourcesBeing cash positive makes this far more likely to happen sooner rather than later. DEMG has a lot going for it right now and needs to seize the moment and look for a buyer. Step 1 is to get the share price nearer to where it should be. Today's announcement is good and needs to be shouted about by the Company and both its firms of brokersCompany is cash positive, profitable and worth today at least twice the market cap rising to at least three to four times for an exitExpect the price to move up over next week or two to at least 2.0p, maybe 2.5p with more to come after the half year reportThat should confirm return to growth in second halfMrC
schloo: Discuss what?There are loan notes. AgreedIf DEMG issues lots more shares, then there will be more shares in issue. Agreed. But it's cash positive now and profitable so no need to issue more shares. It's also on track to get share price above conversion priceIf it issues half a billion new shares to add to the half billion already in issue then it will have one billion shares. AgreedBut it won't get from 500 to 1,000 by issuing 200 or converting loan notes as per your scenario. Where in your head is the other 250 million shares coming from?Yet again you can't even make stuff up coherentlyBye bye buywell
Deltex Medical share price data is direct from the London Stock Exchange
Your Recent History
Deltex Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191209 04:34:00